THC BioMed Intl Ltd. is now shipping THC Kiss Gummies to the Canadian recreational and medical markets. Shipments are beginning with the province of Saskatchewan, with other provinces to follow.
“We are proud to introduce our second cannabis edible product under our Kiss brand to the market and look forward to introducing several more products over the next few months,” said John Miller, President and CEO of THC BioMed.
THC Kiss Gummies are infused using proprietary extraction methods invented by THC BioMed. Each THC Kiss Gummy contains 2.5 mg of THC, with each package containing 4 THC Kiss Gummies.
THC BioMed is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is on the leading edge of scientific research and the development of products and services related in the medical cannabis industry. Management believes THC BioMed is well-positioned to be in the forefront of this rapidly growing industry.